# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-136268
Filing Date
2021-11-09
Accepted
2021-11-09 16:05:47
Documents
60
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cldx-20210930x10q.htm iXBRL | 10-Q | 1398241
2 | EX-31.1 | cldx-20210930xex31d1.htm | EX-31.1 | 13201
3 | EX-31.2 | cldx-20210930xex31d2.htm | EX-31.2 | 13165
4 | EX-32.1 | cldx-20210930xex32d1.htm | EX-32.1 | 7703
| Complete submission text file | 0001104659-21-136268.txt |  | 6231488

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA | cldx-20210930.xsd | EX-101.SCH | 30189
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | cldx-20210930_cal.xml | EX-101.CAL | 46190
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | cldx-20210930_def.xml | EX-101.DEF | 121673
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | cldx-20210930_lab.xml | EX-101.LAB | 356528
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | cldx-20210930_pre.xml | EX-101.PRE | 254441
10 | EXTRACTED XBRL INSTANCE DOCUMENT | cldx-20210930x10q_htm.xml | XML | 1396384

Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 211392068
SIC: 2835 In Vitro & In Vivo Diagnostic Substances